• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ginsenoside Rg3

Ginsenoside Rg3

Product ID G3556
Cas No. 38243-03-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $102.20 In stock
5 mg $255.30 In stock
10 mg $428.70 In stock
25 mg $816.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ginsenoside Rg3 is a triterpene saponin originally found in species of Panax (ginseng) that exhibits neuromodulatory, cognition enhancing, anti-inflammatory, antioxidative, anti-angiogenic, and anticancer chemotherapeutic activities. Ginsenoside Rg3 activates KCNQ1 K+ channels and the γ2 subunit of GABA-A receptors and inhibits the α10 subunit of nicotinic acetylcholine receptors (nAChRs). In animal models, ginsenoside Rg3 decreases expression of TNF-α, IL-1β, and COX-2 in the hippocampus, improving learning and memory deficits. In vitro, ginsenoside Rg3 prevents LPS-induced upregulation of TNF-α, IL-1β, and IL-6 levels and decreases activation of microglia. In other animal models, this compound decreases oxidative stress by increasing activity of catalase, superoxide dismutase (SOD), and lysozyme and decreasing levels of NO and malondialdehyde. Ginsenoside Rg3 also exhibits anti-angiogenic benefit, inhibiting VEGF/p38/ERK signaling to inhibit tubular formation and migration of endothelial progenitor cells. In osteosarcoma cells, this compound increases DNA damage by inducing strand breaks into double-stranded DNA.

Product Info

Cas No.

38243-03-7

Purity

≥98%

Formula

C42H72O13

Formula Wt.

785.01

IUPAC Name

2-[4,5-dihydroxy-2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4, 4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16, 17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl) oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Synonym

20-(R)-Ginsenoside Rg3

Solubility

Soluble in methanol 0.1 mg/mL. DMSO to 5 mM.

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

G3556 MSDS PDF

Info Sheet

G3556 Info Sheet PDF

References

Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A985132

    AZD-8186

    Selective inhibitor of PI3Kβ and PI3Kδ.

    ≥99%
  • L582694

    Lorlatinib

    Third generation macrocyclic ALK inhibitor.

    ≥98%
  • M2400

    MG-132

    Proteasome inhibitor.

    ≥98%
  • P3592

    Pixantrone Dimaleate

    Aza-anthracenedione, DNA intercalator; topoisom...

    ≥98%
  • G124090

    GDC-6036

    KRAS inhibitor

    ≥98%
  • E4668

    ELR-510444

    Microtubule polymerization inhibitor.

    ≥98%
  • D3356

    Diosmetin

    O-methylated flavone found in vetch and various...

    ≥98%
  • E5575

    Entacapone

    COMT inhibitor.

    ≥98%
  • E4416

    Eledoisin

    Peptide, substance P analog; NK agonist.

    ≥95%
  • C0245

    Calcitonin Gene Related Peptide, rat

    Endogenous calcitonin-family peptide, involved ...

    ≥95%
  • G1310

    GDC-0349

    mTOR inhibitor.

    ≥98%
  • D017538

    Danoprevir

    May be useful against COVID-19

    ≥98%
  • D1792

    Dextromethorphan Hydrobromide Hydrate

    σ1/2and μ/κ/δ-OR agonist, α3β4/α4β2/α7...

    ≥98%
  • R1627

    Regorafenib Anhydrous

    Multikinase inhibitor.

    ≥99%
  • L1044

    LCL-161

    SMAC mimetic; PXR agonist, IAP inhibitor.

    ≥99%, ≥99%ee, de
  • A5070

    Angiotensin Acetate

    Peptide, derivative of AT I, cleavage product o...

    ≥95%
  • G4480

    Glucagon, human

    Endogenous peptide hormone, counteracts insulin...

    ≥95%
  • C1632

    Cefotaxime Acid

    β-lactam cephalosporin; penicillin binding pro...

    ≥91%
  • I7456

    1-Isothiocyanato-7-(methylsulfinyl)-heptane

    ITC, radical scavenger.

    ≥98%
  • T1852

    Tenovin-1

    SIRT1/2 inhibitor, indirect p53 activator.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only